Caroline Vayne

Université de Tours

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Thijs van Haaps

AMC Research Institute

NETHERLANDS

View details

Thorsten Bartsch

Professor

Christian-Albrechts-Universität zu Kiel

GERMANY

View details

Yves Gruel

MD, Professor

FRANCE

View details

Aurélien Lebreton

Université Clermont Auvergne

FRANCE

View details

Fabrice Vuillier

Université de Franche-Comté

FRANCE

View details

Pierre SIE

Pr, Head of laboratory

Université Toulouse III - Paul Sabatier

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Caroline Vayne

Research Interests

Explore related searches

Contact this professor

Articles (10)

Effectiveness and safety of therapeutic plasma exchange to modify the functionality of heparin-induced thrombocytopenia antibodies and correct profound thrombocytopenia: A case report and literature review

Variable serotonin release assay pattern and specificity of PF4‐specific antibodies in HIT, and clinical relevance

Multicentre evaluation of 5B9, a monoclonal anti‐PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Reply to the letter entitled “Suggested treatment of serious complications to Covid‐19 vaccination with IdeS, a bacterial antibody‐cleaving enzyme”

Acquired platelet defect associated with gabapentin treatment: a case-report

Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels

Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia

Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination

Prospective evaluation of two specific IgG immunoassays (HemosIL® AcuStar HIT‐IgG and HAT45G®) for the diagnosis of heparin‐induced thrombocytopenia: A Bayesian approach

Collaborators (6)

Thijs van Haaps

Thorsten Bartsch

Yves Gruel

Aurélien Lebreton

Fabrice Vuillier

Pierre SIE

Make your next move.